Laura Sepp-Lorenzino
Chief Tech/Sci/R&D Officer bij INTELLIA THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Dr. Laura Sepp-Lorenzino is een Onafhankelijk Bestuurder bij Taysha Gene Therapies, Inc. en een Chief Scientific Officer & Executive VP bij Intellia Therapeutics, Inc. Ze zetelt in de Raad van Bestuur van Taysha Gene Therapies, Inc. Dr. Sepp-Lorenzino was voordien werkzaam als VP, Head-Nucleic Acid Therapies & Research bij Vertex Pharmaceuticals, Inc., als Vice President bij Alnylam Pharmaceuticals, Inc. en als Executive Director & Head-RNA Therapeutics bij Merck & Co., Inc. Zij behaalde haar doctoraal aan de Universidad de Buenos Aires, een graduaat aan de New York University en een doctoraat aan de New York University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-03-2024 | 81 893 ( 0.09% ) | 2 M $ | 31-03-2024 | |
18-09-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Laura Sepp-Lorenzino
Bedrijven | Functie | Begin |
---|---|---|
INTELLIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28-05-2019 |
TAYSHA GENE THERAPIES, INC. | Director/Board Member | 23-11-2020 |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | - |
Eerdere bekende functies van Laura Sepp-Lorenzino
Bedrijven | Functie | Einde |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-05-2019 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-09-2017 |
MERCK & CO., INC. | Director/Board Member | 01-03-2014 |
Opleiding van Laura Sepp-Lorenzino
New York University | Doctorate Degree |
Universidad de Buenos Aires | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
INTELLIA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Taysha Gene Therapies, Inc. |